Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally Temple

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Molecular Neurodegeneration|October 15, 2025
Modeling neurodegeneration in the retina and strategies for developing pan-neurodegenerative therapiesEmily L Ward, Larry Benowitz, Thomas M Brunner, et al.
Molecular Neurodegeneration|March 22, 2022
Solving neurodegeneration: common mechanisms and strategies for new treatmentsLauren K Wareham, Shane A Liddelow, Sally Temple, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Improved Protocol for Reproducible Human Cortical Organoids Reveals Early Alterations in Metabolism with <i>MAPT</i> MutationsTaylor Bertucci, Kathryn R Bowles, Steven Lotz, et al.
Scientific Reports|August 24, 2021
High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathyChialin Cheng, Surya A Reis, Emily T Adams, et al.
Nature|December 9, 2024
A framework for neural organoids, assembloids and transplantation studiesSergiu P Pașca, Paola Arlotta, Helen S Bateup, et al.
Molecular Psychiatry|June 17, 2025
Cell autonomous microglia defects in a stem cell model of frontotemporal dementia tauAbhirami K Iyer, Lisa Vermunt, Farzaneh S Mirfakhar, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
<i>MAPT</i> Splicing Modulators as a Therapeutic Strategy for TauopathiesM Catarina Silva, Hannah Lindmeier, Paolo Pigini, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
<i>APOE-</i> ε4-induced Fibronectin at the blood-brain barrier is a conserved pathological mediator of disrupted astrocyte-endothelia interaction in Alzheimer's diseasePrabesh Bhattarai, Elanur Yilmaz, Elif Öykü Cakir, et al.
Cell|July 27, 2021
ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoidsKathryn R Bowles, M Catarina Silva, Kristen Whitney, et al.
Stem Cell Reports|November 28, 2015
Creating Patient-Specific Neural Cells for the In Vitro Study of Brain DisordersKristen J Brennand, M Carol Marchetto, Nissim Benvenisty, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Molecular Neurodegeneration|October 15, 2025
Modeling neurodegeneration in the retina and strategies for developing pan-neurodegenerative therapiesEmily L Ward, Larry Benowitz, Thomas M Brunner, et al.
Molecular Neurodegeneration|March 22, 2022
Solving neurodegeneration: common mechanisms and strategies for new treatmentsLauren K Wareham, Shane A Liddelow, Sally Temple, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Improved Protocol for Reproducible Human Cortical Organoids Reveals Early Alterations in Metabolism with <i>MAPT</i> MutationsTaylor Bertucci, Kathryn R Bowles, Steven Lotz, et al.
Scientific Reports|August 24, 2021
High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathyChialin Cheng, Surya A Reis, Emily T Adams, et al.
Nature|December 9, 2024
A framework for neural organoids, assembloids and transplantation studiesSergiu P Pașca, Paola Arlotta, Helen S Bateup, et al.
Molecular Psychiatry|June 17, 2025
Cell autonomous microglia defects in a stem cell model of frontotemporal dementia tauAbhirami K Iyer, Lisa Vermunt, Farzaneh S Mirfakhar, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
<i>MAPT</i> Splicing Modulators as a Therapeutic Strategy for TauopathiesM Catarina Silva, Hannah Lindmeier, Paolo Pigini, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
<i>APOE-</i> ε4-induced Fibronectin at the blood-brain barrier is a conserved pathological mediator of disrupted astrocyte-endothelia interaction in Alzheimer's diseasePrabesh Bhattarai, Elanur Yilmaz, Elif Öykü Cakir, et al.
Cell|July 27, 2021
ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoidsKathryn R Bowles, M Catarina Silva, Kristen Whitney, et al.
Stem Cell Reports|November 28, 2015
Creating Patient-Specific Neural Cells for the In Vitro Study of Brain DisordersKristen J Brennand, M Carol Marchetto, Nissim Benvenisty, et al.
Pageof 15